Tradestie Institutional Equity Comparison Engine

ABEO vs CISS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABEO Overall Edge

ABEO Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Options & Structure while CISS counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, ABEO trades at 18.7x Forward P/E with -186.1% operating margin (+2745.0% YoY revenue) versus CISS at N/M Forward P/E and 24.6% operating margin (+249.0% YoY). In options structure, ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro) against CISS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABEO
ABEO 18.7x vs CISS N/M Fwd P/E
Growth & Margin Winner CISS
Op Margin -186.1% vs 24.6% ยท YoY +2745.0% vs +249.0%
Momentum & Technical Winner CISS
1Y -42.4% vs -25.4% ยท 52W Pos 6% vs 20%
Options & Structure Winner ABEO
BREAKDOWN (27th %ile IV) vs BREAKDOWN (N/A IV)
ABEO NASDAQ
Abeona Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.42
-1.22% 1D
Market Cap $167.4M
1M Return -45.86%
1Y Return -42.38%
Forward P/E 18.7x
Unified AI Score
49.9 / 100 HOLD
Tech 60.0 Fund 61.0 Flow 67.0 Mom 55.0
CISS NASDAQ
C3is Inc. Common Stock
Deep Sea Foreign Transportation Of Freight
$1.23
+4.24% 1D
Market Cap $991,199
1M Return +135.23%
1Y Return -25.45%
Forward P/E N/M
Unified AI Score
33.6 / 100 SELL
Tech 5.0 Fund 29.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABEO -42.38% CISS -25.45% Spread: +16.93 pp (CISS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ABEO Revenue CISS Revenue ABEO Op. Margin CISS Op. Margin Margin Edge
FY2017 $0M N/A -3325.7% N/A ABEO
FY2018 $0M N/A -1940.2% N/A ABEO
FY2020 $10M N/A -814.2% N/A ABEO
FY2021 $0M N/A -2994.5% N/A ABEO
FY2022 $0M N/A -3600.8% N/A ABEO
FY2023 $0M $30M -1346.7% 36.3% CISS
FY2024 N/A $40M N/A 23.8% CISS
FY2025 $10M $30M -1536.9% 3.9% CISS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABEO (6) vs CISS (4)
Institutional Metric ABEO CISS Criterion Row Winner
Market Capitalization Scale $167.4M $991,199 Larger Scale ABEO
Trailing P/E Ratio Valuation 18.7x N/M Lower Multiple ABEO
Forward P/E Ratio Valuation 18.7x N/M Lower Multiple ABEO
Revenue Growth (YoY) Growth +2745.0% +249.0% Higher Growth ABEO
Operating Margin (TTM) Profitability -186.1% 24.6% Higher Margin CISS
Net Profit Margin Profitability -160.3% 27.4% Higher Margin CISS
Return on Equity (ROE) Capital Efficiency -42.1% 17.1% Higher ROE CISS
52-Week Range Position Momentum 6% ($2โ€“$8) 20% ($0โ€“$6) Stronger Trend CISS
Beta / 30D Volatility Risk Regime 0.60ฮฒ ยท 149% Vol 11.91ฮฒ ยท 1054% Vol Lower Realized Risk ABEO
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 33.6 / 100 (SELL) Higher Composite ABEO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABEO vs CISS Buy Guide
ABEO BREAKDOWN
71d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABEO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CISS BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CISS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABEO nor CISS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.